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The oct==peps,de corrmpondmii to human mtcrferon.~j (Hu IFN.a=) sequence 131-1.18 hat high ~tffinity eo murine thym~yte i¢ceptors 
(K., ,- 4,2 x I 0  '= M. about 700 receptors per cell) The pepttde/r~eptor binding i,t inhtbstcd by both Ht| ri FN.== (K, = I~ 6 x I0" '= M) and thymosin. 
=, ( ' rM.=,)  (K,,. 3 :. 10"  M) as well as by the oetapeplide homologous Io the TM.=, sequence 16=23 (K,,,=4,S x 10=' M), The pep==de from IFN,'= s 
(I~,I-138) activates murine thynlocyt¢ blast transfonnutmn at u conctntratmn of I0 ='' M m the presence or 2 s l~g,ml ofconcanavalln A. 
lnterreron.=; Thymosln.=t. Common receptor 
l INTRODUCTION 
Interferons are polyfunctional proteins possessing 
anttv~ral, antitumor and tmmunomodulatory activities 
i l l .  In order to localize the active sites of these proteins 
we predicted the secondary and three-d=mensmnal 
structures of IFNs-a~, -#, "7, "~ [2-7] from their amino 
acid ~equences, and revealed the conservative amino 
acid residues by means of the analysis of 72 IFNs-u, -#, 
-w [6,7]. Three conventional clusters of conservative 
posRions were =dent=fled: the 'loop' one - residues 
30-39; 'hydrophilic' - residues 59-92; and 
'hydrophoblc' - residues 123-144 [7]. It ~s reasonable 
to assume that the loop sites at the regina of conser- 
vative clusters can d~rectly participate m the formation 
of IFN active s~tes. Parttcular attention was drawn to 
the loop segment at the region of amino acid residues 
130-140. This segment was shown [5-7] to have the 
highest homology with the thymus hormone, thymosm- 
at (TM-aq) [8]. It is reasonable to suppose that this se- 
quence corresponds to the immunomodulatory s|te of 
IFNs slm|lar, in some features, to TM-~.  
We report here the syn;hes~s of the peptides cor- 
responding to the region of the h:ghest homology be- 
tween IFN-a~2 and TM-~t together with the study of 
their binding by murme thymocytes and mvesugatton 
of thezr bmlog~cal ctwity. 
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2. MATERIALS AND METHODS 
TM.~, [8] and the pcplides corresponding to the segments of the 
hIRhest homology between IFN.a.~ and TM.otz ~,¢re obta,ned by the 
sohd-phase synthes,s The pep=ides were purifted by HPLC on a 
chromatograph (Gflsor, France) using Zorbax C,, columns (DuPont, 
USA) According to the optical data at 220 nn~, the content of the 
butk substance was found to be 99¢/0 The peptld¢ structure was con- 
firmed by the amino ac,d analysis under standard condttions on a 
DS00 amino acid analyzer (Durrum, USA) Optical rotat,on was 
re<assured w,th a 141M polarmleter (Perkzn-Elmor. USA). Peptad¢ 
iothnatlon was carned out according to the procedure suggested by 
Ltng ¢t al [9]. The labelled peps,de was purified from radmlysed pro- 
duets and impurtttes by gel ill=rattan using a 0 9 x 10 mm column of 
Sephadex G-10 (Pharmacla, Sweden) equlhl~rated with 0 0S M 
phosphate buffer, pH 7 5 Purity of the labelled pep==de was tested 
by than-layer chromatography on alummlum ox,de glass plates w,th 
the solvent system, n.butanol/acetle acid/water (4.1 1), followed by 
autorad,ography The preparations obtained contained not more 
than S% of degradation products Radioactiv,ty was measured with 
a Mint Oamr~a Counter ..LKB, Sweden) For ttte analysis of spectflc 
binding, the cells (10 ~ per ml) were Incubated at 4=C for 40 mm w,th 
rad,olabelled IFN-~= oetapeptlde (concentration range from 10 ' '= to 
10 -'~ M) m soluttoa of 50 mM Tns.HCl buffer wRh bacaracm (0.1 
mg/r~l), trypsin tnhtbttor f om soybean (0.1 mg/ml), EGTA (1 raM), 
PMSF (0 6 rag/l) Non-specff,c bmdmg was determined m the 
presence of I0 "s M unlabelled IFN.a= peptsd= The incubation was 
terminated by rapid fdtrat,on through GF/B glass fiber filters (What- 
man, UK) under vacuum pressure Filters werennsed tw=ce with 5 ml 
volumes of ice-cold buffer. Each experiment was repeated and all the 
samples were analyzed at least m duphcate. 
For the analysis of inhibitory effects murm¢ thymoeytes (lOV-IO 8 
cells/ml) were incubated for 40 rain at 4"C with unlabelled thymosm. 
aq (concentration range from 10 ' '= to 10 -~ M) and 0.3 nM of 
rad,olabelled IFN-a.2 octapeptzde m solution ofSO mM Tns.HCI buf- 
fer w~th bac,tracm (0 1 mg/ml), EGTA (i raM), PMSF (0 6 mJz/I) 
and trypsin rahab,tot from soybean (0 1 mg/ml) The incubus=on was 
terminated by rapid fihratmn through GF/B glass fiber filters (What- 
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m~n, UK} under v~¢uum prel~ur#. Filters w~re rinsed twice wish ~l,ml 
volume~ of lee.cold buffer. Celh in dupll<ale lu t~ were ~yed for 
e~h concentration. ~nd e=~h e,tperimenl w~ replicated 3=4 tirol,. 
The lnhlbhion constant (K,)was t~l~uhlted from Ihe ~uation I lOl: 
ICu, 
I + [LIK., 
wh~e i l l  Is the coltcentrl~Hon or I~belled hlland and Kd is the 
=qudibrlum constant |C~ v~lues were delwmlned |rmphlc=dly (~ee 
Fill, 2). 
For the ~n&lyds or bl~Hr~nsformlnll a~.livity of the pepllde~, 
thyrnocytes were ~¢dtlvaled for "/2 h in ~6.well plates E~ch well ~on. 
lained S x 10 ~ ~.ells in 200/~1 of RPMI.16-t0 medium tO,bee, UK) slip. 
plemenled wllh $~', Inactivated calf fetal serum, S mM Itepcs, 20 rnM 
lllutamin and 100 unlts/ml or both penl~:lllln ~nd streptomycin I!1 h 
before lermmllion of the cullivCillon, [)HJlhymldln In I ,~Ci doses 
was added to each well To ~tssess the rei~ClZOn efficiency, the stirnula 
lion index was det0rmi~ted ~s the ratio or the number or r~dlO~tCllVe 
impulses in the experimental ceils to thai in tile control ones (culture 
medium free of the s~mple under study), Con A (Serves, USA) at Ihe 
concentration of 2 ~/,8/ml was used as n milollen, The s~rnple of Hu 
rl FN,~= was kindly provided by Dr V, Bumyal,s (Institute of Applied 
Enzymology, Vdnyus, L=thy=tnta) 
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Fig I. S~atchuird ~nalyn,~ or the specific binding of Ihe ~'i,labclled 
octapeptlde, LKEKKY,SP (¢orr=spondmll IO the IFN.nz sequence 
I} l - I ) ,8) wilh routine thyrnocyies, B/F Implies Ihe r~llo of molar 
con¢cnlration or tile bound I=bdled pcplide (El) to Ih~t of tile free 
lat~elled oeLapept=de IF) 
3. RESULTS 
Table I, column 2 shows primary strum.lures of the 
synthesized peptsdes, and column I indicates their 
origin. All the peptides share a common sequence, 
LKEKK.  Parameters of bmdlng with thymocyt¢ recep- 
tors were determined for the peptides efficiently labeH. 
ed with taSl. The unlabelled peptides were studied in a 
test of inhibition of binding of the most actwe (among 
those studied) labelled IFN-e~z peptide, LKEKKYSP. 
The analysis of binding of the IFN-~= peptide with 
thymocytes by the method in [10] (Fig. 1) revealed one 
type of thymocyte receptor (Scatchard plot represents a
direct line). The bmdln8 =s characterized by high affini- 
ty (R'd =4.2x  10 "=2 M, see Table I) and by a relatively 
low density of binding sites per cell ( -700) .  The 
unlabelled rIFN-o~2 and TM.o~ mhtblt the binding of 
the labelled IFN-=z2 octapeptide (Kl = 8,6 x 10- ,o M and 
3 x 10 "7 M, respectively) (Fig. 2, Table I). Inhibitory 
activity of TM-ut is reproduced by the TM-cz~ 16-23 oc- 
tapeptide (K1=4.5 x l0 "7 M, Table l). Extension of the 
active sequence with one residue from the C-terminus 
induces afflmty decrease by a factor of I0' (Table D. 
Extension of the same sequence from the N.terminus 
results m a loss of  binding capacity (Table I), The pen- 
tapeptide corresponding to the sequence LKEKK, 
shared by IFN.~= and TM-~t,  does not produce any in- 
hibitory effect on the receptols (Table I). This Indicates 
an important role of the sequence YSP for the interac- 
tion with receptors. Its replacement with the sequence 
EVV m TM-~I (16-23) significantly decreases the pep- 
tide binding capactty (Table l). 
The IFN-ot= octapeptide can be comparable with 
rIFN-o~z m the reactmn of  blast transformation (Fig. 3). 
In the presence of  low doses of Con A (2,5/~g/ml) the 
pcpttdc at a concentratzon of 10-at M induces 
Table 1 
Parameters of binding of Ha rlFN-a=, TM-~'I and peplkdes, corresponding to the cytok2ne sequences, with thyrnocyte receptors 
Pept=de origin Peps=lie sequence Kd(M) KL(M) 
Hu IFN-czz Hu rlFN-ocz nd* 8 6x 10 -I° 
IFN-cz2 031-138) LKEKKYSPC 6 2x 10 -s i 
IFN,.,:zz (131-138) LKEKKYSP 4 2x l0 -*= i 
IFN-az (131-135) LKEKK nd m °** 
lFN-a,z (126-135) RITLYLKEKK nb*" m 
IFN-czz (123-13•) YFQRITLYLKEKK nb nl 
IFN-~z Cys (Acm) (131-138)'*** CLKEKKYSP nb nz 
IFN-o2 [(131-138) C-Cys]z LKEKKYSPC 
LKEKKYSPC nb m 
TM a~l TM-ul nd 3 x 10 -7 
TM-~ (16-23) LKEKKEVV nd 4 5 x I0 -~ 
TM-oq (i i-20) ITTKDLKEKK nd m 
*Non-demrmmed 
**Non.bound 
***Non-inhibited 
****Pepude dzrner,zauon is blocked by Cys modffzcauon wzth Acre- (ac~tamzdomcthyl) group 
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Fill 2 Inhibitory erfec[~ or thyntodn.+~) on the blndmll or the )~1, 
labelled IFMn-= (131-1]~) o¢t=tl)eptidc. The arrow i~ldlcale) 11~¢ 
=raphlc mode of ¢~tlmation of IC~. ~alue 
thymocy/e blast transformation more eff iciently than 
r IFN-u=. 
4. D ISCUSSION 
The experimental data obtained provide evidence 
that the sequence 131-138 of  [FN.a.= is responsible for 
binding to high.aff inity receptors on murme 
thymocytcs, The fact that Hu  rIFN-¢z= effectively in- 
hlbits this reactivity indicates the lack o f  essentzal 
species-distinctions in IFN.oa binding by the given bin- 
ding site, These receptors are common to IFN-uz and 
TM-a=, since both cytokines exert an tnhibztory effect 
on the blndtng of the radlolabelled octapeptide IFN-a= 
(131-138). In TM-tzL the sequence 16-23 IS responsible 
for this activity. Since binding of  the IFN-~z= octapep- 
t~de (131-138) with thymocyte receptors is characteriz- 
ed by a linear Scatchard plot, it can be concluded that 
the receptor identlty is independent of a subpopulauon 
of ceils and extent of their differentiation, The blnding 
of  radtolabelled IFN-a to cells was studied m many 
tissue culture cells f rom both mice and humans [12], A 
wlde variety o f  cell types have a relatlvely low number 
(2× I02 to l x I04) of  hlgh-afflnity (Kd of  I × I0 -9 tO 
I X I0 -z~ M) receptors for IFN.~,  Many blndmg curves 
do not show true saturatlon resulting In curvilinear 
Scatchard plots, Some authors suggested that this 
reflects the presence of a fairly large number  of low- 
aff inity receptors in additlon to the h~gh-afflmty ones 
[12], Our results provlde evidence that the sequence 
130-140 of IFN-= corresponds to the h~gh-affinity bln- 
dlng slte of  thls protein, According to our unpublished 
data the IFN-a2 peptide 131-138 does not reproduce 
antlvtral actlvlty o f  IFN but has some im- 
munomodulatory  properties in common. The IFN-oa 
fragment 131-138 seems to correspond only to a part of 
the immunomodulatory stte of  the given cytoklne, 
b 
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i 
' 1;.1~1' ' ' i;.i, M 
F)il 3, ActhallOn of mnri11¢ Ihymoeyle blS=Sl IransformatllOn by the 
O¢lapeptlde LKEKKYSP (a) and Hu rlFN..] (b) In ehe presence of 
0.25 il/ml Con A The quan|il~' or r~dloAelive impuls(=s per minute 
(cpm, counter per i~=nule) Is plotted as the ordinate an~ molar 
concentrat=ons or the octapeptide (,~) and rIFN-~= (b) are plotted as 
the abscissa, Thymocytes were cultivated for ~2 h in 96.w¢11 plates, 
Each well ~:onmined Sx 10 ~ cells In 200/d of RPMI.1640 medium 
supplemenled with $% mactwated calf fetal serum, S mM Hopes, 20 
mM Illutamln© and I00 un=ts/ml or both peni¢ilhn and streptomycin, 
18 h before term=nation of the cuhlvation, [~H]thymidme tn I ,~C= 
doses was added ¢0 each well. The control t was the ¢ul|ure medium 
free of the sample under study, and the control 2 was the culture 
mcdmm + 2,S/~8/ml Con A used as a ~tfitogen. 
slnc¢, at the molar level, tt reproduces only the blast- 
transforming actlvlty of IFN-u. 
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